dr. markman discusses the olaparib phase ii trial
Published 13 years ago • 305 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
1:25
olaparib in ovarian cancer
-
1:36
dr. markman discusses the future of treatment for ovarian cancer
-
11:22
olaparib in ovarian cancer
-
1:36
dr. markman discusses treating ovarian cancer as chronic disease
-
1:12
dr. markman on the search for actionable biomarkers in ovarian cancer
-
2:20
dr. markman on overall survival as an endpoint in ovarian cancer trials
-
2:59
dr. markman on the future of treatment for ovarian cancer
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
2:14
dr. markman on immune targeting in ovarian cancer
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
0:49
dr. tung discusses the role of olaparib in breast cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
1:20
dr. ledermann discusses olaparib in ovarian cancer
-
8:41
parp inhibitors for ovarian cancer: use of olaparib
-
2:11
dr. markman on endpoints in clinical trials for ovarian cancer
-
1:56
dr. markman on precision medicine in ovarian cancer
-
2:32
dr. markman on the era of precision medicine in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
2:05
dr. markman on 2017 goals for the field of ovarian cancer